Health News Releases

  • Today December 20
November 07, 2019 18:41
Takeda’s Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that results from the primary endpoint analysis of the ongoing pivotal Phase 3 Tetravalent Immunization against Den
November 07, 2019 16:14
Takeda Unveils New Dengue Vaccine Manufacturing Plant in Germany
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the opening of its new manufacturing plant in Singen, Germany, for its dengue vaccine candidate, TAK-003. The Singe
November 07, 2019 15:48
Samsung Bioepis Enters into Commercialization Agreement for Next-Generation Biosimilar Candidates
Samsung Bioepis Co., Ltd. announced today that it has entered into a new commercialization agreement with Biogen (Nasdaq: BIIB) for two biosimilar candidates under development by Samsung Bioepis, SB11
November 06, 2019 18:02
Octapharma’s fibryga® Receives European Label Extension to Treat Acquired Fibrinogen Deficiency (AFD)
Octapharma announced today that the human fibrinogen concentrate fibryga® has received approval for use in treatment of acquired fibrinogen deficiency (AFD) in 15 European countries. The approval exte
November 06, 2019 16:01
Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform
The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced an exclusive license agreement and research agreement to deve
November 05, 2019 16:14
Takeda Continues Strategic Divestitures With Sale of Select OTC and Non-Core Assets to STADA for $660 Million USD
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select products to STADA Arzneimittel AG (“STADA”),
November 04, 2019 16:23
Takeda Reports Solid Second Quarter FY2019 Results and Raises Profit Guidance for the Full Year
Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191030006224/en/ Underl
November 01, 2019 18:06
The Mary Kay Foundation Awards $3.1 Million in Cancer Research and Domestic Violence Shelter Grants
The Mary Kay FoundationSM recently awarded over $3 million in cancer research and domestic violence shelter grants around the country. The Mary Kay Foundation was established in 1996 with the overarch
November 01, 2019 17:38
Octapharma announces publication of data on fibryga® for the treatment of acquired fibrinogen deficiency in patients undergoing cardiac surgery
Octapharma has announced the publication of new data demonstrating that the fibrinogen concentrate fibryga® is an effective alternative to cryoprecipitate for patients with severe bleeding during card
November 01, 2019 14:57
Promethera Biosciences: Announcement Regarding Business Activities in Japan
Promethera Biosciences SA (Group), a global innovator in cell-based medicines and liver diseases, announced the foundation of a new branch office in Tokyo, Promethera Biosciences Japan Branch Ltd on M
November 01, 2019 13:02
Masimo Announces CE Marking of Radius Capnography™ for the Root® Patient Monitoring and Connectivity Platform
Masimo (NASDAQ: MASI) announced today that Radius Capnography™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received CE marking. Radius Capnography connects with the Roo
October 31, 2019 16:29
The Mary Kay Foundation Donates $100,000 to Baylor Scott & White to Support Triple Negative Breast Cancer Research
The Mary Kay Foundation℠, a decades-long leader in the mission to eliminate cancers affecting women, recently donated $100,000 to Baylor Scott & White Dallas Foundation to help fund research conducted
October 30, 2019 13:41
Terns Pharmaceuticals Receives Fast Track Designation From the FDA for TERN-101, an FXR Agonist for the Treatment of NASH
Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, today announced tha
October 30, 2019 10:26
Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing
Boehringer Ingelheim today presented promising preclinical data from its pan-KRAS program including the novel, oral inhibitor BI 1701963 at the AACR-NCI-EORTC International Conference on Molecular Tar
October 28, 2019 11:33
A Decade of Innovation and Growth: Cook Korea 10th Anniversary
Cook Medical celebrated its 10-year anniversary with a special event that marked a major milestone - a decade of successful customer service, innovation and employee development. Back in 2000, Cook
October 25, 2019 08:00
Global Health Progress Launched to Drive Cross-sectoral Collaborations in Support of the Sustainable Development Goals (SDGs)
To support the SDGs, with a particular focus on SDG 17: Partnership for The Goals, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has launched Global Health Progre
October 23, 2019 19:10
Covetrus Announces CEO and Chairman Transition
Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that Benjamin Shaw has stepped down as the company’s president and chief executive officer and will t
October 23, 2019 17:01
Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharmaceuticals Following Positive Phase 2a Proof-of-Concept Study
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) and COUR Pharmaceutical Development Company, Inc. (“COUR”) today announced that Takeda has acquired an exclusive global license to
October 23, 2019 11:06
Solasia Announces Approval of episil® oral liquid in South Korea
Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”), a specialty pharmaceutical company based in Asia, today officially announced that e
October 22, 2019 11:13
ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask
ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube - a brand-new option for sleep apnea treatment. ResMed’s light
October 21, 2019 16:43
Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from a retrospective chart review study (EVOLVE), which investigated the likelihood of serious adverse even
October 21, 2019 13:18
New Research Reveals Updated Patient Preferences on Digital Health Technology
ResMed (NYSE: RMD, ASX: RMD) today announced results from a company-led survey, revealing new patient preferences on digital health technology. The survey highlights a reason for optimism that the mar
October 21, 2019 10:35
Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products
The CE certified products/brands are as listed below: 1. MagicTouch - PTA (Sirolimus Coated PTA Balloon Catheter) for peripheral arterial disease 2. MagicTouch - ED (Sirolimus Coated Balloon Cathe
October 18, 2019 13:10
Sonion Joins Global Qualcomm Extension Program
Sonion®, global leader in designing and manufacturing components and solutions for hearing aids, in-ear earphones and hearables/wearables, today announced that it is now a member of the Qualcomm® Exte
October 17, 2019 14:20
Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation Host Pandemic Exercise and Livestream
The Johns Hopkins Center for Health Security, with the World Economic Forum and the Bill & Melinda Gates Foundation, will host Event 201, a multimedia global pandemic exercise on Friday, Oct. 18, 2019
25 per page50 per page75 per page100 per page